期刊文献+

经皮冠状动脉介入治疗术前的负荷剂量他汀类药物治疗 被引量:10

原文传递
导出
摘要 急性冠状动脉综合征(ACS)患者采用经皮冠状动脉介入治疗(PCI)已经成为冠状动脉血运重建的最佳手段之一。ACS的发病与冠状动脉局部斑块病变不稳定和炎症反应有关。PCI本身可能会引起血管壁的损伤和炎症反应,进而引起心肌损伤。他汀类药物的调脂和抗炎症作用,为拓宽他汀类药物的临床应用提供了依据。近年来,在PCI围术期应用他汀类药物负荷剂量治疗受到重视,这种治疗策略应用于何种类型的冠心病更有价值,值得探讨。
作者 廖玉华
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第1期1-3,共3页 Journal of Clinical Cardiology
  • 相关文献

参考文献3

  • 1VESELKA J, ZEMANEK D, HAJEK P, et al Effect of two-day atorvastatin pretreatment on the Incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study[J]. Am J Cardiol,2009,104:630-633.
  • 2NICHOLLS S J, BRANDRUP-WOGNSEN G, PALMER M, et al. Meta-analysis of comparative efficacy of increasing dose of atorvastatin versus rosuvastatin versus Simvastatin on lowering levels of atherogenie lipids (from VOYAGER) [J]. Am J Cardiol,2010,105: 69-76.
  • 3YUN K H, JEONG M H, KYU S, et al. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome[J]. Int J Cardiol,2009,137 : 246-251.

同被引文献82

  • 1Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广(译),王淑敏(译),胡大一(校).极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志(中文版),2006,25(4):215-223. 被引量:341
  • 2Rosuvastatin Registration Clinical Trial Group.Cardiovascular Institute and Fu Wai Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100037,China.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量:117
  • 3PATTI G, PASCERI V, COLONNA G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention., results of the AR- MYDA-ACS randomized trial[J]. J Am Coil Cardiol, 2007,49:1272-1278.
  • 4KIM J S, KIM J, CHOI D, et al. Efficacy of highdose atorvastatin loading before primary percutaneous coronary intervention in ST-Segment elevation myocardial infarction: the STATIN STEMI trail[J]. JACC Cardiovasc Interv, 2010,3 : 332- 339.
  • 5SVILAAS T, VLAAR P j, VAN DER HORST I C, et al. Thrombus aspiration during primary percutane- ous coronary intervention[J]. N Engl J Med, 2008, 358:557-567.
  • 6SARDELLA G, MANCONE M, CANALI E, et al. Impact of thrombectomy with EXPorT Catheter in Infarct-Related Artery during Primary Percutaneous Coronary Intervention (EXPIRA Trial) on cardiac death[J].Am J Cardiol, 2010,106 : 624- 629.
  • 7VLAAR P J, SVILAAS T, VAN DER HORST I C, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS) : a 1-year follow-up study [J]. Lancet, 2008,371 : 1915-1920.
  • 8HEESTERMANS T, SURYAPRANATA H, TEN BERG J M, et al. Facilitated reperfusion with prehospital glycoprotein IIb/lIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCI [J]. J Electrocardiol,2011,44:42-48.
  • 9HERMANIDES R S, VAN HOUWELINGEN G, OTTERVANGER J P, et al. The impact of age on effects of pre-hospital initiation of high bolus dose of tirofiban before primary angioplasty for ST-elevation myocardial infarction [J].Cardiovasc Drugs Tber, 2011,25:323-330.
  • 10WINCHESTER D E, WEN X, XIE L, et al. Evidence of pre-procedural statin therapy a meta-analysis o[ ran- domized trials[J]. J Am Coil Cardiol, 2010,56 : 1099 - 109.

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部